AXA Health has launched a neurodiversity assessment and support service as part of its group private healthcare scheme.
The service, supported by ProblemShared, will provide members with neurodiverse conditions access to assessments, diagnosis and onward assistance, targeted at supporting staff members with autism, ADHD, dyslexia, dysgraphia and dyscalculia. The onward support includes medication reviews for attention deficit hyperactivity disorder (ADHD) and post-assessment group sessions for autism and ADHD. The benefit will be available to members from early October 2022 with members able to add the corporate schemes at renewal. It will also be available to eligible family members over 7 years old. ...
To continue reading this article...
Join COVER for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.
